Phenotypically immature IgG-bearing B cells in patients with hypogammaglobulinemia.

PubWeight™: 0.92‹?›

🔗 View Article (PMID 3485652)

Published in J Clin Immunol on January 01, 1986

Authors

M Fiorilli, M Crescenzi, M Carbonari, L Tedesco, G Russo, C Gaetano, F Aiuti

Articles by these authors

Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's disease. Nat Genet (2013) 9.46

Ability of HIV to promote a TH1 to TH0 shift and to replicate preferentially in TH2 and TH0 cells. Science (1994) 3.62

Relative increase of T cells expressing the gamma/delta rather than the alpha/beta receptor in ataxia-telangiectasia. N Engl J Med (1990) 2.69

Human lymphocyte subpopulations: classification according to surface markers and-or functional characteristics. Transplant Rev (1973) 2.53

Effectiveness of early prednisone treatment in preventing the development of nephropathy in anaphylactoid purpura. Eur J Pediatr (1992) 2.50

Tcl1 enhances Akt kinase activity and mediates its nuclear translocation. Proc Natl Acad Sci U S A (2000) 2.48

Development of a highly efficient expression cDNA cloning system: application to oncogene isolation. Proc Natl Acad Sci U S A (1991) 2.48

Differential and stage-related expression in embryonic tissues of a new human homoeobox gene. Nature (1987) 2.42

Constitutive activation of NF-kappaB and T-cell leukemia/lymphoma in Notch3 transgenic mice. EMBO J (2000) 2.41

Functional and morphological recovery of dystrophic muscles in mice treated with deacetylase inhibitors. Nat Med (2006) 2.25

Clinical and immunologic response without decrease in virus load in patients with AIDS after 24 months of highly active antiretroviral therapy. Clin Infect Dis (1999) 2.17

Delta-beta-thalassemia is due to a gene deletion. Cell (1976) 2.12

Low frequency of alterations of the alpha (PPP2R1A) and beta (PPP2R1B) isoforms of the subunit A of the serine-threonine phosphatase 2A in human neoplasms. Oncogene (2000) 2.08

Identification of the TCL1 gene involved in T-cell malignancies. Proc Natl Acad Sci U S A (1994) 2.02

Human herpesvirus 8 seropositivity and risk of Kaposi's sarcoma and other acquired immunodeficiency syndrome-related diseases. J Natl Cancer Inst (1999) 2.01

Abnormal or absent beta mRNA in betao Ferrara and gene deletion in delta beta thalassaemia. Nature (1976) 1.96

Deregulated expression of TCL1 causes T cell leukemia in mice. Proc Natl Acad Sci U S A (1998) 1.86

Inhibition of ErbB-2 mitogenic and transforming activity by RALT, a mitogen-induced signal transducer which binds to the ErbB-2 kinase domain. Mol Cell Biol (2000) 1.85

Human TCR-gamma+/delta+, CD8+ T lymphocytes recognize tetanus toxoid in an MHC-restricted fashion. J Exp Med (1989) 1.82

Cloning of the gene encoding the delta subunit of the human T-cell receptor reveals its physical organization within the alpha-subunit locus and its involvement in chromosome translocations in T-cell malignancy. Proc Natl Acad Sci U S A (1988) 1.74

Laparoscopic and open treatment of hepatocellular carcinoma in patients with cirrhosis. Br J Surg (2009) 1.74

Molecular mechanisms of human hemoglobin switching: selective undermethylation and expression of globin genes in embryonic, fetal, and adult erythroblasts. Proc Natl Acad Sci U S A (1983) 1.68

Erythropoietin alone induces erythroid burst formation by human embryonic but not adult BFU-E in unicellular serum-free culture. Blood (1989) 1.64

Acidosis inhibits endothelial cell apoptosis and function and induces basic fibroblast growth factor and vascular endothelial growth factor expression. Circ Res (2000) 1.60

Alpha 6 beta 4 and alpha 6 beta 1 integrins associate with ErbB-2 in human carcinoma cell lines. Exp Cell Res (1997) 1.58

Impaired production of interleukins in patients with cell-mediated immunodeficiencies. Clin Exp Immunol (1983) 1.55

Isotypic analysis of antibody response to a food antigen in inflammatory bowel disease. Int Arch Allergy Appl Immunol (1985) 1.52

Antibiotic resistance in Pseudomonas aeruginosa: an Italian survey. J Antimicrob Chemother (1998) 1.51

Two human homeobox genes, c1 and c8: structure analysis and expression in embryonic development. Proc Natl Acad Sci U S A (1987) 1.50

Cytokine and chemokine levels in systemic sclerosis: relationship with cutaneous and internal organ involvement. Clin Exp Immunol (2004) 1.46

Function and distribution pattern of human T lymphocytes. I. Production of anti-T lymphocyte specific sera as estimated by cytotoxicity and elimination of function of lymphocytes. Clin Exp Immunol (1973) 1.46

Plasma viraemia in seronegative HIV-1-infected individuals. AIDS (1991) 1.43

Peptide analogues as a strategy to induce tolerance in T cells with indirect allospecificity. Transplantation (2000) 1.43

High efficiency myogenic conversion of human fibroblasts by adenoviral vector-mediated MyoD gene transfer. An alternative strategy for ex vivo gene therapy of primary myopathies. J Clin Invest (1998) 1.43

Regulation of TCL1 expression in B- and T-cell lymphomas and reactive lymphoid tissues. Cancer Res (2000) 1.40

CFD analysis of gas explosions vented through relief pipes. J Hazard Mater (2006) 1.39

Human embryonic hemopoiesis. Kinetics of progenitors and precursors underlying the yolk sac----liver transition. J Clin Invest (1986) 1.39

Expression of E1A in terminally differentiated muscle cells reactivates the cell cycle and suppresses tissue-specific genes by separable mechanisms. Mol Cell Biol (1996) 1.33

Reconstitution of cyclin D1-associated kinase activity drives terminally differentiated cells into the cell cycle. Mol Cell Biol (2001) 1.32

Abnormalities at 14q32.1 in T cell malignancies involve two oncogenes. Proc Natl Acad Sci U S A (1999) 1.30

Ras family genes: an interesting link between cell cycle and cancer. J Cell Physiol (2002) 1.29

Controlling centrality in complex networks. Sci Rep (2012) 1.28

A human homoeo box gene specifically expressed in spinal cord during embryonic development. Nature (1986) 1.26

Chronic lymphocytic leukemia and regulatory B cells share IL-10 competence and immunosuppressive function. Leukemia (2012) 1.26

The ATM gene and susceptibility to breast cancer: analysis of 38 breast tumors reveals no evidence for mutation. Cancer Res (1996) 1.26

Structure and growth-dependent regulation of the human cyclin B1 promoter. Exp Cell Res (1995) 1.26

Inhibition of lipid peroxidation restores impaired vascular endothelial growth factor expression and stimulates wound healing and angiogenesis in the genetically diabetic mouse. Diabetes (2001) 1.25

Laparoscopic approach in the treatment of epiphrenic diverticula: long-term results. Surg Endosc (2004) 1.25

MicroRNA profiling reveals that miR-21, miR486 and miR-214 are upregulated and involved in cell survival in Sézary syndrome. Cell Death Dis (2011) 1.25

Embryonic----Fetal Hb switch in humans: studies on erythroid bursts generated by embryonic progenitors from yolk sac and liver. Proc Natl Acad Sci U S A (1984) 1.24

Natural killer cells in intravenous drug abusers with lymphadenopathy syndrome. Clin Exp Immunol (1985) 1.24

Terminally differentiated skeletal myotubes are not confined to G0 but can enter G1 upon growth factor stimulation. Cell Growth Differ (1996) 1.23

Chromosome walking on the TCL1 locus involved in T-cell neoplasia. Proc Natl Acad Sci U S A (1993) 1.22

Photon scattering as a probe of microviscosity and channel size in gels such as sickle haemoglobin. Nature (1983) 1.22

Surface markers on lymphocytes of patients with infectious diseases. Infect Immun (1973) 1.21

Suprascapular neuropathy in volleyball players. J Bone Joint Surg Am (1987) 1.19

Skin lesions in diabetes mellitus: prevalence and clinical correlations. Diabetes Res Clin Pract (1998) 1.19

Selective deficiency of CD4+/CD45RA+ lymphocytes in patients with ataxia-telangiectasia. J Clin Immunol (1992) 1.18

CD8+ T lymphocytes provide helper activity for IgE synthesis in human immunodeficiency virus-infected patients with hyper-IgE. J Exp Med (1995) 1.16

Evidence for activation of complement in patients with AIDS related complex (ARC) and/or lymphoadenopathy syndrome (LAS). Clin Exp Immunol (1987) 1.15

Interference with p53 protein inhibits hematopoietic and muscle differentiation. J Cell Biol (1996) 1.15

Encephalocraniocutaneous lipomatosis: complete neuroradiologic evaluation and follow-up of two cases. AJNR Am J Neuroradiol (1999) 1.13

In situ evidence of neoplastic cell phagocytosis by macrophages in papillary thyroid cancer. J Clin Endocrinol Metab (1997) 1.13

Astrocyte cultures from human embryonic brain: characterization and modulation of surface molecules by inflammatory cytokines. J Neurosci Res (1992) 1.12

Autotaxin protects MCF-7 breast cancer and MDA-MB-435 melanoma cells against Taxol-induced apoptosis. Oncogene (2008) 1.12

Mismatch repair, G(2)/M cell cycle arrest and lethality after DNA damage. Carcinogenesis (1999) 1.11

Characterization and localization of the TCL-1 oncogene product. Cancer Res (1994) 1.11

Genome-wide association study of Alzheimer's disease with psychotic symptoms. Mol Psychiatry (2011) 1.11

High frequency of cancer in cold thyroid nodules occurring at young age. Acta Endocrinol (Copenh) (1989) 1.10

Proliferative and cytotoxic responses to mannoproteins of Candida albicans by peripheral blood lymphocytes of HIV-infected subjects. Clin Exp Immunol (1991) 1.10

Dual action of retinoic acid on human embryonic/fetal hematopoiesis: blockade of primitive progenitor proliferation and shift from multipotent/erythroid/monocytic to granulocytic differentiation program. Blood (1996) 1.09

Laparoscopic treatment of Bochdalek hernia without the use of a mesh. Surg Endosc (2003) 1.08

Long-term evaluation of T-cell subsets and T-cell function after HAART in advanced stage HIV-1 disease. AIDS (1999) 1.08

gamma-Interferon production in peripheral blood mononuclear cells and tumor infiltrating lymphocytes from Kaposi's sarcoma patients: correlation with the presence of human herpesvirus-8 in peripheral blood mononuclear cells and lesional macrophages. Blood (1998) 1.08

Hemoglobinopathies in Italy. Hemoglobin (1982) 1.08

The WRN and MUS81 proteins limit cell death and genome instability following oncogene activation. Oncogene (2012) 1.07

TCL1 is overexpressed in patients affected by adult T-cell leukemias. Cancer Res (1997) 1.07

The placenta growth factor gene of the mouse. Mamm Genome (1996) 1.07

Agenesis of the corpus callosum, combined immunodeficiency, bilateral cataract, and hypopigmentation in two brothers. Am J Med Genet (1988) 1.06

Molecular mechanisms underlying the expression of the human HOX-5.1 gene. Nucleic Acids Res (1990) 1.05

C-C chemokines, IL-16, and soluble antiviral factor activity are increased in cloned T cells from subjects with long-term nonprogressive HIV infection. J Immunol (1997) 1.05

Surface markers on human lymphocytes: studies of normal subjects and of patients with primary immunodeficiencies. Clin Exp Immunol (1973) 1.05

p53 re-expression inhibits proliferation and restores differentiation of human thyroid anaplastic carcinoma cells. Oncogene (1997) 1.05

Pathogenesis of the natural killer cell deficiency in AIDS. Immunol Today (1990) 1.04

Mechanism of defective natural killer cell activity in patients with AIDS is associated with defective distribution of tubulin. J Immunol (1988) 1.04

Gastric pathology in patients with common variable immunodeficiency. Gut (1999) 1.04

Comparison of ground reaction forces between obese and control young adults during quiet standing on a baropodometric platform. Clin Biomech (Bristol, Avon) (2003) 1.04

Detection and characterization of apoptotic peripheral blood lymphocytes in human immunodeficiency virus infection and cancer chemotherapy by a novel flow immunocytometric method. Blood (1994) 1.03

TCL1 oncogene activation in preleukemic T cells from a case of ataxia-telangiectasia. Blood (1995) 1.03

Assessment of thymic output in common variable immunodeficiency patients by evaluation of T cell receptor excision circles. Clin Exp Immunol (2002) 1.03

Apoptosis-related mortality in vitro of mononuclear cells from patients with HIV infection correlates with disease severity and progression. J Acquir Immune Defic Syndr Hum Retrovirol (1995) 1.02

The murine Tcl1 oncogene: embryonic and lymphoid cell expression. Oncogene (1997) 1.02